Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease

Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease

US Patent 7378111 · Granted May 27, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monoclonal antibodies against alpha-synuclein fibrils2024
Substituted [1,2,4]triazolo[1,5-a]pyrimidines for stabilizing microtubules2023
Monoclonal antibodies against alpha-synuclein fibrils2022
Monoclonal antibodies against pathological alpha-synuclein, and methods using sa2021
Heterocyclic compounds and their use for the treatment of neurodegenerative tauo2017
Cycloalkyl-dione derivatives and methods of their use2017
In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combin2016
In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combin2015
Thromboxane A2 (TP) receptor antagonists2015
Cycloalkyl-dione derivatives and methods of their use2013
Amyloid plaque aggregation inhibitors and diagnostic imaging agents2013
Detection of neurodegenerative disease2013